The level of sex hormones in the tissues and myoma adenomyosis at the independent and combined development

E. M Frantsiyants; V. A Bandovkina; T. I Moiseenko; N. V Chernikova

doi:10.17816/onco40020

Russian Journal of Oncology ›› 2013, Vol. 18 ›› Issue (6) : 24 -27. DOI: 10.17816/onco40020

Articles

research-article

The level of sex hormones in the tissues and myoma adenomyosis at the independent and combined development

Author information +

History +

PDF

Abstract

The levels of sex hormone, prolactin and sex steroid-binding globulin in the tissue of the husteromyoma and adenomyosis at the independent and combined development of pathologies was investigated. Violations in the local hormonal background during the self-adenomiose and husteromyoma. In the case of simultaneous development of two disorders, hormonal background adenomiose tissue practically does not change, but the local hormonal status is converted in husteromyoma. The combined development of the two estrogen dependent pathologies, adenomyosis provided significant influence on myoma, subjecting and reconstructing its local hormonal status, manifested in the decline of estrone and increase the concentration of free estriol, as well as reducing SSG indicators in some patients. Hormones of adenomiose and myoma tissue during combined development of the two disorders may create premorbid background for rebirth and malignancy tissue of the uterus.

Keywords

adenomyosis / husteromyoma / estradiol / estrone / testosterone / prolactin / sex steroid-binding globulin

Cite this article

Download citation ▾

E. M Frantsiyants, V. A Bandovkina, T. I Moiseenko, N. V Chernikova. The level of sex hormones in the tissues and myoma adenomyosis at the independent and combined development. Russian Journal of Oncology, 2013, 18(6): 24-27 DOI:10.17816/onco40020

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Дамиров М.М. Аденомиоз: клиника, диагностика и лечение. М.: Тверь; 2002.

[2]	Стрижаков А.Н., Давыдов А.И. Доброкачественные заболевания матки. М.: ГЭОТАР-Медиа; 2011.

[3]	Гуриев Т.Д. Сочетание миомы матки и аденомиоза: новые аспекты патогенеза, диагностики и лечения: Дис. М.; 2005.

[4]	Rosner W., Hryb D.J., Kahn S.M. Interactions of sex hormone-binding globulin with target cells. Mol. Cell. Endocrinol. 2010; 316(1): 79—85.

[5]	Киселев В.И., Сидорова И.С., Унанян А.Л., Муйженек Е.Л. Гиперпластические процессы органов женской репродуктивной системы: теория и практика. М.; 2011.

[6]	Щепотин И.Б., Зотов А.С., Костюченко Е.А. Роль пролактина в физиологии и патологии молочной железы. Вопросы онкологии. 2007; 53 (2): 131—9.

[7]	Адамян М.Л. Роль некоторых метаболических и морфологических изменений эндометрия в патогенезе рака тела матки: Дис. Ростов-н/Д; 2011.